News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Samaritan Pharmaceuticals, Inc.'s (SPHC) Stem Cell Technology Sparkles With Hope For Alzheimer's Patients



10/19/2005 5:13:02 PM

LAS VEGAS--(BUSINESS WIRE)--March 16, 2005--Samaritan Pharmaceuticals Inc. (AMEX:LIV): -- A Great Deal of Hope Rests with Non-embryonic Stem cell Therapy, (in contrast to controversial embryonic stem cell therapy where stem cells are transplanted from embryos or bone marrow.) -- Non-embryonic Stem cell Therapy Activates Dormant Brain Stem cells in the Patient's Own Brain. -- Samaritan's Drugs could Someday Allow Doctors to Grow and Re-grow Lost cells without Resorting to Surgery. http://www.samaritanpharma.com/images/Samaritan_stemcell.html Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs announced today it has developed a video to conceptualize its promising neural stem cell drugs. Samaritan optimistically believes its self renewing; differentiating, neural stem cell drugs to be therapeutic and possibly cure diseases, such as, Alzheimer's, Parkinson's and Spinal Cord Injuries.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES